All In Biotech

Drugs by condition

Drugs approved for allergies (allergic rhinitis)

Brand-name prescription drugs and biologics whose FDA label lists allergies (allergic rhinitis) as an approved use. Matched on the label phrases: "allergic rhinitis".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

18

Still marketed, NDA or BLA

Drug classes

3

Novel drugs

5

New molecular entities and new biologics

In development

16

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for allergies (allergic rhinitis).

  • Ryaltris (Mometasone Furoate, Olopatadine Hydrochloride) · Glenmark Speclt Jan 13, 2022
  • Karbinal Er (Carbinoxamine Maleate) · Aytu Mar 28, 2013
  • Dymista (Azelastine Hydrochloride, Fluticasone Propionate) · Mylan Speciality Lp May 1, 2012
  • Qnasl (Beclomethasone Dipropionate) · Teva Branded Pharm OrphanMar 23, 2012
  • Omnaris (Ciclesonide) · Azurity NovelOct 20, 2006

All approved drugs for allergies (allergic rhinitis), by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 223 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Corticosteroid (3)

  • Medrol Methylprednisolone · Pfizer · 1957
  • Kenalog-40 Triamcinolone Acetonide · Apothecon · 1965
  • Cortef Hydrocortisone · Pharmacia and Upjohn · 1952

Histamine-1 Receptor Antagonist (2)

Class not listed in FDA's data (13)

  • Omnaris Ciclesonide · Azurity · 2006
  • Singulair Montelukast Sodium · Organon · 1998
  • Celestone Soluspan Betamethasone Acetate, Betamethasone Sodium Phosphate · Organon · 1965
  • Ryaltris Mometasone Furoate, Olopatadine Hydrochloride · Glenmark Speclt · 2022
  • Karbinal Er Carbinoxamine Maleate · Aytu · 2013
  • Dymista Azelastine Hydrochloride, Fluticasone Propionate · Mylan Speciality Lp · 2012
  • Qnasl Beclomethasone Dipropionate · Teva Branded Pharm · 2012
  • Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
  • Singulair Montelukast Sodium · Organon · 1998
  • Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986
  • Depo-Medrol Methylprednisolone Acetate · Pfizer · 1959
  • Solu-Medrol Methylprednisolone Sodium Succinate · Pharmacia and Upjohn · 1959
  • Solu-Cortef Hydrocortisone Sodium Succinate · Pharmacia and Upjohn · 1955

Drugs in development for allergies (allergic rhinitis)

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • CM512Phase 39 trials

    Keymed Biosciences Co.Ltd · Chronic Rhinosinusitis With Nasal Polyposis, Chronic Spontaneous Urticaria (CSU), Asthma

  • LP-003SinglePhase 39 trials

    Longbio Pharma · Allergic Asthma, Chronic Spontaneous Urticaria (CSU), Peanut Allergies

  • SHR-1819Phase 38 trials

    Guangdong Hengrui Pharmaceutical Co., Ltd · Seasonal Allergic Rhinitis, Moderate to Severe Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis

  • JYB1904RPT904, ozureprubartPhase 35 trials

    Jemincare · Chronic Spontaneous Urticaria, Perennial Allergic Rhinitis, Immune System Diseases

  • GR1802Phase 34 trials

    Genrix (Shanghai) Biopharmaceutical Co., Ltd. · Allergic Rhinitis, Seasonal, Allergic Rhinitis, Chronic Rhinosinusitis With Nasal Polyps

  • Shanghai Mabgeek Biotech.Co.Ltd · Atopic Dermatitis, Seasonal Allergic Rhinitis, Chronic Spontaneous Urticaria (CSU)

  • StapokibartPhase 34 trials

    Chengdu Kangnuoxing Biopharma,Inc. · Seasonal Allergic Rhinitis (SAR), Bullous Pemphigoid (BP), Prurigo Nodularis

  • TQH2722Phase 33 trials

    Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Seasonal Allergic Rhinitis, Atopic Dermatitis

  • 000 MM09Phase 32 trials

    Inmunotek S.L. · Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic

  • DEP114Phase 32 trials

    EMS · Persistent Allergic Rhinitis, Allergic Rhinitis

  • EP-088_MM09Phase 32 trials

    Inmunotek S.L. · Allergic Rhinitis, Allergic Rhinoconjunctivitis, Allergic Asthma

  • AK139Phase 26 trials

    Akeso · Asthma, Moderate-to-Severe Atopic Dermatitis, Chronic Spontaneous Urticaria

  • TQC2938Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Chronic Obstructive Pulmonary Disease, Seasonal Allergic Rhinitis

  • ALDP001Phase 21 trial

    Alixer Nexgen Therapeutics Limited · Seasonal Allergic Rhinitis (SAR)

  • INI-2004Phase 21 trial

    Inimmune Corporation · Allergic Rhinitis Due to Allergens, Rhinitis Allergic, Allergic Rhinitis

  • JT002Phase 21 trial

    Shanghai JunTop Biosciences Co., LTD · Seasonal Allergic Rhinitis

3 discontinued brand-name drugs whose label still names it

More on allergies (allergic rhinitis): recruiting trials · published research

Related in respiratory: Pulmonary arterial hypertension · Asthma · COPD · Cystic fibrosis · Idiopathic pulmonary fibrosis

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.